Zeno Equity Partners LLP Sells 42,347 Shares of Danaher Corporation $DHR

Zeno Equity Partners LLP reduced its holdings in Danaher Corporation (NYSE:DHRFree Report) by 15.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 223,448 shares of the conglomerate’s stock after selling 42,347 shares during the quarter. Danaher accounts for 20.0% of Zeno Equity Partners LLP’s portfolio, making the stock its 2nd largest position. Zeno Equity Partners LLP’s holdings in Danaher were worth $51,202,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in DHR. Tyche Wealth Partners LLC acquired a new position in shares of Danaher during the 3rd quarter valued at $462,000. Bank Pictet & Cie Europe AG increased its position in shares of Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after purchasing an additional 74,301 shares during the period. Johnson Investment Counsel Inc. increased its position in shares of Danaher by 2.9% during the 3rd quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock valued at $131,784,000 after purchasing an additional 18,744 shares during the period. Mutual of America Capital Management LLC increased its position in shares of Danaher by 22.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 95,443 shares of the conglomerate’s stock valued at $18,923,000 after purchasing an additional 17,478 shares during the period. Finally, Whittier Trust Co. increased its position in shares of Danaher by 94.5% during the 3rd quarter. Whittier Trust Co. now owns 261,104 shares of the conglomerate’s stock valued at $56,135,000 after purchasing an additional 126,835 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Barclays lowered their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wells Fargo & Company lowered their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Finally, UBS Group lowered their price target on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $238.65.

View Our Latest Analysis on DHR

Danaher Stock Performance

DHR opened at $172.12 on Monday. The firm has a market cap of $121.82 billion, a PE ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business has a fifty day simple moving average of $183.52 and a 200-day simple moving average of $208.70. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company posted $1.88 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.